GL
CLVS

GLG LLC’s Clovis Oncology, Inc. CLVS Stock Holding History

GLG LLC’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$1.9M Hold
27,883
– – 0.14% 184
2017
Q3 		$2.3M Buy
27,883
+18,337
+192% +$1.45M 0.15% 180
2017
Q2 		$894K Sell
9,546
-4,950
-34% -$303K 0.05% 329
2017
Q1 		$923K Buy
+14,496
New +$881K 0.05% 349
2016
Q4 		– Sell
-20,000
Closed -$721K – 552
2016
Q3 		$721K Buy
+20,000
New +$429K 0.05% 326

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

GLG LLC's CLVS Position: Q4 2017 in Review

GLG LLC held its Clovis Oncology, Inc. (CLVS) position steady in Q4 2017 at 27,883 shares worth $1.9M. The position accounts for 0.14% of the portfolio, ranked #184.

GLG LLC first reported a position in CLVS in Q3 2016 and has held it in 5 quarters since. The position peaked at $2.3M in Q3 2017. 247 funds tracked by Wall St. Rank hold CLVS as of Q4 2017.

  • GLG LLC held 27,883 shares of Clovis Oncology, Inc. worth $1.9M as of Q4 2017.
  • GLG LLC left its Clovis Oncology, Inc. share count unchanged in Q4 2017.
  • Clovis Oncology, Inc. made up 0.14% of GLG LLC's portfolio in Q4 2017, its #184 holding.
  • GLG LLC first reported a position in Clovis Oncology, Inc. in Q3 2016 and has held it in 5 quarters since.
  • GLG LLC's Clovis Oncology, Inc. position peaked at $2.3M in Q3 2017.
  • 247 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2017.

Based on GLG LLC's 13F filing for Q4 2017, filed 14 Feb 2018.